Abstract
Background Decision making in public health is limited by data availability where the most recent reports do not reflect the actual trajectory of an epidemic. Nowcasting is a modeling tool that can estimate eventual case counts by accounting for reporting delays. While these tools have generated reliable predictions when designed for specific use cases, several limitations exist when scaling the models to systems composed of multiple distinct surveillance systems. We seek to identify flexible application of nowcasting models to address these problems.
Methods We used a previously developed Bayesian nowcasting tool, which dynamically estimates delay probabilities up to a user-defined maximum delay using a user-defined training window. We tested automated approaches to select the maximum delay and training window, setting maximum delay values at the 90th, 95th, and 99th quantile distribution of the most recently reported data and training windows to the maximum delay plus one week or multiplied by 1.5 or 2.0. We generated and evaluated nowcasts for 321 datasets reflecting COVID-19 cases and dengue cases in different United States jurisdictions. We assessed prediction error and precision via logarithmic scoring and coverage metrics for the most recent three weeks of predictions in each nowcast. We used these metrics to further assess why nowcasts may fail and to compare predictions generated from three different publicly available tools.
Results Using recent data to estimate dynamic delay and training window parameters resulted in nowcast with less error relative to nowcasts made with static parameters for long historic periods. Nowcasts likely to fail could be predicted a priori by the relative width of the prediction intervals and the permutation entropy of the epidemic trend. More complex models do not significantly improve nowcast performance compared to simple models.
Conclusions We tested multiple systems for scaling up nowcasts in a flexible framework. We recommend using dynamic parameter selection and creating a system to suppress nowcasts likely to fail. This requires collaboration with surveillance colleagues to implement data-driven choices to improve the utility of predictions for decision making.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
L.S.B. acknowledges support from FAPERJ (http://www.faperj.br/) grant E-26/201.277/2021 and CNPq (https://www.gov.br/cnpq/) grant 310530/2021-0. Other authors did not receive funding to support this analysis.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This activity was reviewed by CDC to be deemed not human subject research and was conducted consistent with applicable federal law and CDC policy
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
COVID-19 case data are available upon request at https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Restricted-Access-Detai/mbd7-r32t. Dengue case data for 2010 are available from https://github.com/sarahhbellum/NobBS/blob/master/data/denguedat.RData and dengue case data from 2011-2014 were obtained from the Puerto Rico Department of Health. R code is available in a public repository (https://github.com/cdcepi/Nowcasting_scale_up_analysis).
https://data.cdc.gov/Case-Surveillance/COVID-19-Case-Surveillance-Restricted-Access-Detai/mbd7-r32t